Divis logo

BUSINESS SEGMENTS:

GENERICS

Generic APIs are part of our primary focus area. We respect IPR and do not infringe either product or processes covered by valid patents. Our strong commitment to confidentiality has elicited enquiries and tie-ups for supply of APIs that are migrating to generic status in the near future. We are also involved in developing alternate, patent non-infringing processes for such APIs, both for the original inventors and leading generic drug manufacturers.

INTERMEDIATES FOR GENERICS

We supply advanced intermediates for generic APIs that are already out of patent, as also for APIs which are about to enter generic status shortly. Here again, we are having tie-ups with both original investors and generic drug manufacturers.

CUSTOM SYNTHESIS

We undertake custom manufacture of APIs and advanced Intermediates offering competitive advantages over the entire life cycle of the products.

Several MNCs customers audit our facilities regularly in course of their customs manufacture of their products.